BackStar Lake Bioscience , Inc.Zhaoqing Guangdong Overview

Star Lake Bioscience , Inc.Zhaoqing Guangdong Inventory

Latest inventory for 600866.SS: $2.4B.

Get informed when a big investor buys or sells

+ Follow
Inventory
$2.36B
↑ 65.27% YoYΔ $931.38M vs prior year quarter

Peer trimmed avg / median

Loading

Star Lake Bioscience , Inc.Zhaoqing Guangdong Inventory History

Loading

Star Lake Bioscience , Inc.Zhaoqing Guangdong vs. peers: Inventory Comparison

Loading

Star Lake Bioscience , Inc.Zhaoqing Guangdong Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Star Lake Bioscience , Inc.Zhaoqing Guangdong (600866.SS) FAQ

Star Lake Bioscience , Inc.Zhaoqing Guangdong (600866.SS) currently reports a inventory of $2.4B as of September 2026. That compares with $1.4B in the prior-year period — up 65.3% year over year. Use the charts on this page to explore Star Lake Bioscience , Inc.Zhaoqing Guangdong's inventory history and peer comparisons.

Star Lake Bioscience , Inc.Zhaoqing Guangdong's inventory increased from $1.4B to $2.4B — a 65.3% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Star Lake Bioscience , Inc.Zhaoqing Guangdong reported $2.4B in inventory as of September 2026. That compares with $1.4B in the prior-year period — up 65.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $2.4B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Star Lake Bioscience , Inc.Zhaoqing Guangdong, and consider following 600866.SS for alerts when major investors trade the stock.

Star Lake Bioscience , Inc.Zhaoqing Guangdong is classified in the Healthcare sector. On inventory, it currently shows $2.4B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 600866.SS with unrelated industries.